Cardiac arrest due to hyperkalaemia following suxamethonium 11/ a patient 'With f,eneralizcd spasticity due to head injury is reported and discussed.
Hyperkalaemia following the use of suxamethonium is well documented in patients with certain neurological diseases and injuries (Gronert and Theye 1975) . Patients reported to be • at risk' usually have recognizable • disuse' of motor units. However, in the following report the syndrome occurred in a patient with head injury and generalized spasticity.
CASE REPORT
A 17 -year-old male sustained a severe brainstern injury and a fractured mandible. He maintained a hyperextended rigid posture with decerebrate responses to most stimuli. Aspiration pneumonia and pneumothorax necessitated a tracheostomy.
His neurological picture changed little and 47 days after the injury a laryngoscopy and bronchoscopy were undertaken prior to the permanent removal of his fenestrated tracheostomy tube. Whilst being mechanically ventilated through a cuffed tracheostomy tube, he was given diazepam 20 mg and d-tubocurarine !) mg intravenously, followed 4-5 minutes later by suxamethonium 100 mg. During laryngoscopy the patient's initial tachycardia slowed slightly and he became pale with a feeble femoral pUlse. This responded in a few seconds to head down tilt and gentle hand ventilation with 100% O 2 ; the incident was ascribed to over vigorous positive pressure ventilation. Hyperkalaemia was not considered as continuou,; ECG monitoring showed sinus rhythm throughout, with no characteristic T wave changes.
As muscle power returned before the bronchoscopy was completed, a further dose of suxamethonium 75 mg and atropine 0·4 mg wa,; given intravenously. Three to four minutes later, ventricular fibrillation occurred. This reverted spontaneously to sinus rhythm with peaked T waves after about 90 seconds of cardiac massage and continued ventilation, together with the administration of sodium bicarbonate 100 mEq. The plasma potassium, which had been 3· 4 mEq/L only two hours previously was measured at the time the sinus rhythm returned and was found to be 8·9 mEq/L with normal acid base status, and it wasl·6 mEq/L half an hour later. Subsequent progress was uneventful. COMMENT Hyperkalaemia after suxamethonium in patients with burns, massive trauma and certain neurological conditions is well recognized. An exaggerated sensitivity to suxamethonium because of disuse of the neuromuscular apparatus may be a common cause (Gronert and Theye 1975) . Initially the reported cases with neurological deficits showed obvious disuse of musclE' groups secondary to upper or lower motor neurone lesions. However, in patients with tetanus (Roth and Wiithrich 1969) and encephalitis (Cowgill et al. J 974) , muscle overactivity was a prominent fE'ature. The hyper-Allaesthesia and Intensive Care, 1'01.1 I', So. 3, August, 1!}'j(j sensitivity to suxamethonium in these may have resulted from damage to and subsequent disuse of fibres in the overactive muscles. Alternatively, the hypersensitivity may have been in muscle groups thrown into disuse by reciprocal inhibition. Prolonged use of muscle relaxants could conceivably have contributed in the tetanus cases.
Why have no difficulties been described following the use of suxamethonium in patients with head injuries? Some may have total body potassium depletion and their hyperkalaemic response may be diminished. Meticulous potassium replacement (as in this case), may uncover the response. Hypotensive episodes during the induction of anaesthesia in such patients are not uncommon but the cause is not often investigated by immediate serum potassium estimation. In this case the first transient episode of circulatory embarrassment could have been similarly passed over if its true cause had not been revealed after the second dose ot suxamethonium. It would therefore be instructive to measure plasma potassium immediately in all cases where circulatory irregularities follow the use of suxamethonium, even in the presence of a normal ECG tracing.
The extent to which pretreatment with a nondepolarizing relaxant will protect patients at risk, depends on the balance between the dose of that relaxant and the degree of functional denervation sensitivity. As the latter is impossible to predict, it would seem safer to use a non depolarizing relaxant instead of suxamethonium when a hyperkalaemic response is possible.
